ArticleAdvances in therapy2020

Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial.

Olivier Bruyère et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.